Last reviewed · How we verify
rTSST-1 Variant Candidate Vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
rTSST-1 Variant Candidate Vaccine (rTSST-1 Variant Candidate Vaccine) — Biomedizinische Forschungs gmbH.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| rTSST-1 Variant Candidate Vaccine TARGET | rTSST-1 Variant Candidate Vaccine | Biomedizinische Forschungs gmbH | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- rTSST-1 Variant Candidate Vaccine CI watch — RSS
- rTSST-1 Variant Candidate Vaccine CI watch — Atom
- rTSST-1 Variant Candidate Vaccine CI watch — JSON
- rTSST-1 Variant Candidate Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). rTSST-1 Variant Candidate Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/rtsst-1-variant-candidate-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab